0001477932-22-004667.txt : 20220624 0001477932-22-004667.hdr.sgml : 20220624 20220624160549 ACCESSION NUMBER: 0001477932-22-004667 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220623 FILED AS OF DATE: 20220624 DATE AS OF CHANGE: 20220624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butera Salvatore Thomas CENTRAL INDEX KEY: 0001834339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36833 FILM NUMBER: 221040060 MAIL ADDRESS: STREET 1: 13215 BEE CAVE PARKWAY, STREET 2: SUITE 125, GALLERIA OAKS B CITY: AUSTIN STATE: TX ZIP: 78738 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VOLITIONRX LTD CENTRAL INDEX KEY: 0000093314 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911949078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13215 BEE CAVE PARKWAY, STREET 2: SUITE 125, GALLERIA OAKS B CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 1 (646) 650-1351 MAIL ADDRESS: STREET 1: 13215 BEE CAVE PARKWAY, STREET 2: SUITE 125, GALLERIA OAKS B CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: STANDARD CAPITAL CORP DATE OF NAME CHANGE: 19990812 4 1 form4.xml FORM 4 X0306 4 2022-06-23-05:00 false 0000093314 VOLITIONRX LTD VNRX 0001834339 Butera Salvatore Thomas 13215 BEE CAVE PARKWAY, SUITE 125, GALLERIA OAKS B AUSTIN TX 78738 false true false false CEO - Volition Veterinary Stock Option (Right to Buy) 3.40 2022-06-23-05:00 4 A false 34060 0 A 2031-08-03-05:00 Common Stock 34060 52400 D On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 34,060 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 17,030 shares on each of August 3, 2022 and August 3, 2023, respectively. As reported in April 2022, the rights with respect to the remaining 18,340 shares subject to the award previously vested and remain subject to time-based vesting. /s/ Salvatore Thomas Butera 2022-06-24-05:00